femasys(FEMY) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Femasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate Update -- Recruitment of the commercial team for our infertility portfolio and the pivotal trial of FemBloc® for permanent non- surgical birth control continues -- ATLANTA, May 9, 2024 -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible and innovative therapeutic and diagnostic produc ...